Bm phenotype with weak anti-B serum activity
Villaça, J.A.; Sad, W.E.; de Lima, L.M.; Rouger, P.
Amb Revista da Associacao Medica Brasileira 28(5-6): 148-150
1982
ISSN/ISBN: 0102-843X PMID: 6820528 Document Number: 183772
Document emailed within 1 workday
Related Documents
Wager, O.; Räsänen, J.A.; Haltia, K.; Wasastjerna, C. 1971: M components with antibody activity. Anti-smooth muscle, anti-thyroglobulin and anti-streptolysin-O activity in five M component sera Annals of Clinical Research 3(2): 86-97Fox, A.E. 1978: Standardization of the anti-complement activity in Coombs serum Minerva Medica 69(37): 2530-2534
2001: Comprehensive anti-adrenergic therapy. It can save the weak heart MMW Fortschritte der Medizin 143(4): 45
Ono, K.; Hattori, T.; Inokuchi, K. 1972: Effect of dextran sulphate on immunosuppresive activity of anti-lymphocyte serum Japanese Journal of Experimental Medicine 42(2): 165-170
Lavrova, T.R.; Rodshteĭn, O.A.; Kositskaia, L.S.; Fridman, E.M.; Savel'vol'f, G.B. 1978: Anti-complement activity and blood serum cryoglobulins in rheumatoid arthritis Terapevticheskii Arkhiv 50(9): 68-72
Schwartz, E.; Svejnochová, M.; Siposová, E. 1989: Different effects of a weak static and a weak rotating magnetic field on the growth of mycobacteria Bratislavske Lekarske Listy 90(11): 787-792
Gutman, N.R.; Kul'berg, A.I. 1973: Increase in the specific activity of anti-influenza serum by the use of antiglobulin antibodies and their bivalent F(ab')2-fragments Biulleten' Eksperimental'noi Biologii i Meditsiny 76(7): 71-74
Daruliza, K.M.A.; Yang, K.L.; Lam, K.L.; Priscilla, J.T.; Sunderasan, E.; Ong, M.T. 2011: Anti-Candida albicans activity and brine shrimp lethality test of Hevea brasiliensis latex B-serum European Review for Medical and Pharmacological Sciences 15(10): 1163-1171
Asbrink, E.; Hovmark, A. 1984: Serum IgE levels in patients with bullous pemphigoid and its correlation to the activity of the disease and anti-basement membrane zone antibodies Acta Dermato-Venereologica 64(3): 243-246
Zivković, V.; Stanković, A.; Cvetković, T.; Mitić, B.; Kostić, S.; Nedović, J.; Stamenković, B. 2014: Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus Srpski Arhiv Za Celokupno Lekarstvo 142(7-8): 431-436
Takeda, M.; Machida, M.; Nakano, T.; Tsukada, N.; Yanagisawa, N. 1986: A case of vasculitic neuropathy with pulmonary tuberculosis, anti-endothelial cells activity and increased serum level of immune complexes Rinsho Shinkeigaku 26(7): 727-732
Manuilov, I.A.; Orlova, V.G.; Dzhuraeva, M.K. 1973: Blood estrogen, acetylcholine and cholinesterase content during weak labor activity Akusherstvo i Ginekologiia 49(6): 16-19
Werner, S. 2012: Promoting physical activity and incontinence in the elderly. Weak bladder and unsteady gait Pflege Zeitschrift 65(3): 184-185
Cleuren, A.C.A.; Postmus, I.; Vos, H.L.; Reitsma, P.H.; van Vlijmen, B.J.M. 2011: Progestins possess poor anti-estrogenic activity on murine hepatic coagulation gene transcription despite evident anti-estrogenic activity on uterine tissue Thrombosis Research 128(2): 200-201
Zou, W.-h.; Qiu, S.-q.; Hong, X.-p.; Wu, Q. 2013: Serum myeloperoxidase activity and serum paraoxonase-1 activity in patients with silicosis and observation subjects and their clinical significance Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 31(1): 58-60
Holm, G.; Hammarström, S. 1973: Haemolytic activity of human blood monocytes. Lysis of human erythrocytes treated with anti-A serum Clinical and Experimental Immunology 13(1): 29-43
Brecher, A.S.; Yang, M.P. 1998: Acetaldehyde inhibits chymotrypsin and serum anti-chymotrypsin activity Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research 46(4): 146-152
Williams, R.C.; Malone, C.C.; Silvestris, F.; Nickerson, K.G. 1997: Benign monoclonal gammopathy with IgG anti-DNA, anti-Sm and anti-F(ab')2 activity Clinical and Experimental Rheumatology 15(1): 33-38
Mollison, K.W.; Fey, T.A.; Gauvin, D.M.; Sheets, M.P.; Smith, M.L.; Pong, M.; Krause, R.; Miller, L.; Or, Y.S.; Kawai, M.; Wagner, R.; Wiedeman, P.E.; Clark, R.F.; Gunawardana, I.W.; Rhoades, T.A.; Henry, C.L.; Tu, N.P.; BaMaung, N.Y.; Kopecka, H.; Liu, L.; Xie, Q.; Lane, B.C.; Trevillyan, J.M.; Marsh, K.; Luly, J.R. 1998: Discovery of ascomycin analogs with potent topical but weak systemic activity for treatment of inflammatory skin diseases Current Pharmaceutical Design 4(5): 367-379
Nakamura, H.; Kadokawa, T.; Nakatsuji, K.; Nakamura, K. 1970: Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. I. Anti-inflammatory, analgesic and anti-pyretic activity Arzneimittel-Forschung 20(8): 1032-1046